Vantage Consulting Group’s Ingevity NGVT Stock Holding History

Vantage Consulting Group’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-38	Closed	-$3K	–	1045
2020 Q4	$3K	Buy	+38	New	+$2.48K	﹤0.01%	1576

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBCM

Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

AAM

Ardevora Asset Management London, United Kingdom $1.12B AUM 26.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Vantage Consulting Group's NGVT Position: Q1 2021 in Review

Vantage Consulting Group sold out of Ingevity (NGVT) in Q1 2021, closing a stake of 38 shares — an estimated $3K sold.

Vantage Consulting Group first reported a position in NGVT in Q4 2020 and held it in 1 quarter. The position peaked at $3K in Q4 2020. 286 funds tracked by Wall St. Rank hold NGVT as of Q1 2021.

Vantage Consulting Group reported no remaining Ingevity position as of Q1 2021 after selling out during the quarter.
Vantage Consulting Group sold 38 Ingevity shares in Q1 2021, an estimated $3K.
Vantage Consulting Group first reported a position in Ingevity in Q4 2020 and held it in 1 quarter.
Vantage Consulting Group's Ingevity position peaked at $3K in Q4 2020.
286 funds tracked by Wall St. Rank held Ingevity as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.